Postoperative Exercise Training in Patients With Colorectal Liver Metastases Undergoing Surgery (ELMA)
ELMA
1 other identifier
interventional
60
1 country
1
Brief Summary
Surgery is a primary treatment modality in the intended curative treatment of colorectal liver metastases (CRLM). However, surgery elicits a cascade of potentially detrimental stress responses that may drive the onset of long-term disease progression. Exercise training is emerging as an adjunct treatment in surgical oncology and holds potential to modify the surgical stress response. Against this background, we designed the present randomized controlled trial to evaluate the therapeutic role of pre- and postoperative exercise training in patients with CRLM undergoing open liver resection.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Mar 2021
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 29, 2021
CompletedFirst Posted
Study publicly available on registry
February 12, 2021
CompletedStudy Start
First participant enrolled
March 12, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
March 1, 2026
CompletedNovember 18, 2023
November 1, 2023
2.5 years
January 29, 2021
November 16, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Serious adverse events
From discharge to 8 weeks after discharge
Secondary Outcomes (17)
Postoperative hospital admissions
From discharge to 8 weeks after discharge
Relative dose intensity (RDI) of adjuvant chemotherapy
From date of planned initiation of adjuvant chemotherapy until 8 weeks after discharge
Time to initiation of adjuvant chemotherapy
From surgery until 8 weeks after discharge
Patient-reported symptomatic adverse events
Baseline, 7 days after discharge, 7 days after each administration of adjuvant chemotherapy, 8 weeks after discharge.
Surgical stress: IL-1β
Baseline, after last incision, after resection, 3 hour post-surgery, postoperative day 1, postoperative day 3, postoperative day 15, 8 weeks after discharge
- +12 more secondary outcomes
Other Outcomes (75)
3-years cancer-specific survival
Randomization to 3 years after randomization
3-years overall survival
Randomization to 3 years after randomization
Carcinoembryonic antigen (CEA)
Baseline, postoperative day 15, 8 weeks after discharge
- +72 more other outcomes
Study Arms (2)
Standard care alone (CON)
NO INTERVENTIONParticipants allocated to CON receive the standard patient care program, as provided by Rigshospitalet, Copenhagen, Denmark. Participants allocated to CON are allowed to exercise on their own initiative or participate in any standard care hospital- or municipality-based exercise training program.
Postoperative exercise training and standard care (EX)
EXPERIMENTALParticipants allocated to EX receive the standard patient care program, as provided by Rigshospitalet, Copenhagen, Denmark, and postoperative exercise training. The postoperative exercise training program consists of 8 weeks of supervised and home-based exercise 5 times/week. The intensity and duration are progressively increased during the postoperative period
Interventions
Perioperative exercise training
Eligibility Criteria
You may not qualify if:
- Age \<18
- Pregnancy
- Other known malignancy requiring active cancer treatment that prohibits execution of test or training procedures
- Conditions that prohibit execution of trial procedures
- Inability to understand the Danish language.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Rigshospitalet
Copenhagen, Denmark
Related Publications (1)
Thomsen SN, Krabek R, Yfanti C, Sjoberg S, Sundberg A, Dalsgaard DM, Thomsen LM, Aasvang EK, Qvortrup C, Mau-Sorensen M, Pedersen BK, Larsen PN, Sillesen MH, Schultz NA, Christensen JF, Simonsen C. Postoperative Exercise Training in Patients with Colorectal Liver Metastases A Randomized Controlled Trial. Ann Surg. 2024 Nov 11. doi: 10.1097/SLA.0000000000006587. Online ahead of print.
PMID: 39523954DERIVED
MeSH Terms
Conditions
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Jesper F Christensen, PhD
Centre for Physical Activity Research, Rigshospitalet, University of Copenhagen, Denmark
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- INVESTIGATOR, OUTCOMES ASSESSOR
- Masking Details
- The participants and the exercise intervention instructors cannot be blinded, given the nature of the intervention. The outcome assessors of the primary and key secondary outcomes (adverse events and markers of surgical stress, respectively) will be blinded. For practical reasons, the outcome assessors of the following secondary outcomes will be not be blinded: resting cardiovascular factors, aerobic capacity, muscle strength, functional performance, and body composition and anthropometrics.
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal investigator
Study Record Dates
First Submitted
January 29, 2021
First Posted
February 12, 2021
Study Start
March 12, 2021
Primary Completion
September 1, 2023
Study Completion
March 1, 2026
Last Updated
November 18, 2023
Record last verified: 2023-11
Data Sharing
- IPD Sharing
- Will not share